Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Gynecologic 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peripheral Sensory Neuropathy 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Multiple Myeloma 1Infertility, Female 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Acetylcarnitine × Clear all
NCT05767515 2026-02-09

PCOS

Khyber Medical University Peshawar

Phase NA Completed
120 enrolled

Infertility, Female, Polycystic Ovary Syndrome

NCT00581919 2019-12-13

Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma

University of Wisconsin, Madison

Phase 2 Completed
32 enrolled 8 charts
Plasma cell

Multiple Myeloma

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Bayer

Phase 2 Completed
150 enrolled
GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms

NCT01526564 2013-11-11

Clinical Study on Acetyl-L-Carnitine

Lee's Pharmaceutical Limited

Phase 3 Completed
239 enrolled

Peripheral Sensory Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡